Inventor
CUI JINGRONG JEAN
US21 patents
⚠️ This page may combine multiple inventors who share the name “CUI JINGRONG JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TURNING POINT THERAPEUTICS INC
8 patentsUS10618912B2Apr 14, 2020
Diaryl macrocycles as modulators of protein kinases
TURNING POINT THERAPEUTICS INC5 citations83
US11981684B2May 14, 2024
Macrocyclic compounds and uses thereof
TURNING POINT THERAPEUTICS INC1 citations72
US11286264B2Mar 29, 2022
Macrocyclic compounds and uses thereof
TURNING POINT THERAPEUTICS INC4 citations72
US11155563B2Oct 26, 2021
Macrocyclic compounds and uses thereof
TURNING POINT THERAPEUTICS INC3 citations72
US10689400B2Jun 23, 2020
Macrocycle kinase inhibitors
TURNING POINT THERAPEUTICS INC7 citations72
US11291667B2Apr 5, 2022
Combination therapy involving diaryl macrocyclic compounds
TURNING POINT THERAPEUTICS INC1 citations62
USRE50634EOct 14, 2025
Diaryl macrocycles as modulators of protein kinases
TURNING POINT THERAPEUTICS INC0 citations61
US12404281B2Sep 2, 2025
Diaryl macrocycles as modulators of protein kinases
TURNING POINT THERAPEUTICS INC0 citations61
PFIZER
5 patentsUS8680111B2Mar 25, 2014
Macrocyclic derivatives for the treatment of diseases
PFIZER54 citations96
US7732604B2Jun 8, 2010
Triazolopyrazine derivatives
PFIZER11 citations83
US9133215B2Sep 15, 2015
Macrocyclic derivatives for the treatment of diseases
PFIZER16 citations82
US9328096B2May 3, 2016
Tropomyosin-related kinase inhibitors
PFIZER2 citations60
US7772246B2Aug 10, 2010
Pyrazole compounds as RAF inhibitors
PFIZER0 citations50
CUI JINGRONG JEAN
3 patentsUS8106197B2Jan 31, 2012
Aminoheteroaryl compounds as protein kinase inhibitors
CUI JINGRONG JEAN48 citations90
US8217057B2Jul 10, 2012
Polymorphs of a c-MET/HGFR inhibitor
CUI JINGRONG JEAN16 citations81
US8785632B2Jul 22, 2014
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
CUI JINGRONG JEAN5 citations70